Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid infusion for traumatic intraparenchymal hemorrhage
IRCT2016031427051N1Phase 3Completed
- Sponsor
- Vicebio
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tranexamic acid in Intracranial Injury and brain hemorrhage (ICH), sponsored by Vicebio. Started May 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Intracranial Injurybrain hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT2016031427051N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016031427051N1.